Intermittent Claudication Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Condition: Intermittent Claudication Interventions: Drug: Cilostazol 100 mg; Drug: PMR 135 mg Sponsor: Genovate Biotechnology Co., Ltd., Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Home-based Exercice Therapy for Patients With Intermittent Claudication Using a New Smartphone Application
Condition: Intermittent Claudication Interventions: Other: E-REVA® app; Other: No E-REVA® app Sponsor: CHU de Reims Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials
A Randomized Clinical Trial for GNX80 in Intermittent Claudication
Condition: Intermittent Claudication Interventions: Drug: GNX80; Drug: Placebo Sponsor: SK Chemicals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2022 Category: Research Source Type: clinical trials